These are best treated with more systemic therapies rather than topical eye drops. Intravenous immunoglobulin (IVIG) and steroids are some of the preferred therapies to treat these issues, though newer LEMS directed systemic therapies like amifampridine are also available
Whilst mild and transient GI symptoms are common with GLP-1 receptor agonists and are generally not a cause for alarm, certain symptoms warrant prompt medical attention
CagriSema vs Retatrutide comparison for 2026: mechanisms, clinical trial status, weight loss data, diabetes relevance, tolerability, and approval outlook
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor Underwood, C.R., Garibay, P., Knudsen, L.B., Hastrup, S., Peters, G.H., Rudolph, R., Reedtz-Runge, S
Expect 4 to 8 pounds during this phase if your nutrition is consistent
However, the situation is changed in high-risk PDA patients